C-REL Recombinant Antibody
Applications
Reactivity
| Overview | |
| Catalog # | bsm-61664r-20uL |
| Product Name | C-REL Recombinant Antibody |
| Applications |
WB
IP
|
| Reactivity | Human |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Rabbit |
| Source | KLH conjugated synthetic peptide derived from human c Rel |
| Clonality | Recombinant |
| Isotype | IgG |
| Concentration | Lot dependent |
| Purification | Purified by Protein A. |
| Storage Buffer | 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| Storage Condition | Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target | |
| Gene ID | 5966 |
| Swiss Prot | Q04864 |
| Subcellular location | Nucleus |
| Synonyms | Avian reticuloendotheliosis; c Rel proto oncogene protein; Oncogene REL; Proto-oncogene c-Rel; REL. |
| Background | Proto-oncogene that may play a role in differentiation and lymphopoiesis. NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. |
| Application Dilution | |
| WB | 1:500-2000 |
| IP | IP1:20-50 |
Frequently asked questions
Which applications is C-REL Recombinant Antibody (bsm-61664R) validated for, and at what dilution?
bsm-61664R is validated for WB(WB) (1:500-2000); IP(IP) (1:20-50). These are recommended starting dilutions; optimal dilutions should be determined by the end user.
Which species does C-REL Recombinant Antibody (bsm-61664R) react with?
Tested reactivity: Human.
How should bsm-61664R be stored?
Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. Storage buffer: 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
What immunogen was used to raise C-REL Recombinant Antibody (bsm-61664R)?
KLH conjugated synthetic peptide derived from human c Rel